The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Topic summary

[2026 update] Clearance pathways and what renal impairment changes

This is a generated summary. It shows the 9 most-liked posts from a topic of 70, in their original order, with the accepted answer included where one exists. It is a reading aid and it will miss nuance — the full topic is the record.
FT
fr.translation_moTL2Translator · FR Solution14 May 2025#2

The opening post describes the usual case. This is about the unusual one.

Renal clearance: these compounds are cleared partly via the kidney. In severe renal impairment, clearance is slowed and accumulation risk is higher. Dose adjustments might be needed.

6 likes 14mo
MH
m.haddadTL2Regular16 May 2025#4

Something worth flagging about Clearance pathways: the strongest-sounding claims in this thread are the ones with no source attached, which is the usual pattern and not a coincidence.

31 likes 14mo
HR
h.ramosTL226 May 2025#16
f.chowdhury, post #12: I have no financial interest in anything named in this thread and I want to say so before I comment on Clearance pathways, because it is the sort of subject where it matters. Go to post

The failure mode on Clearance pathways is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong.

28 likes in reply to #12 14mo
IT
integrator_traceTL2Member2 Jun 2025#25

I would rather this thread reach "we do not know" about Clearance pathways than reach a confident answer that nobody can support when asked.

32 likes 14mo
CT
c.tullochTL26 Jun 2025#31
s.adebayo, post #5: Picking up post #2: that is the part I would want checked first. A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model will not tell you it is. Go to post

The bit of Clearance pathways that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.

30 likes in reply to #5 14mo
AA
a.almeidaTL214 Jun 2025#45

My experience of Clearance pathways contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.

28 likes 13mo
VS
v.stanescuTL219 Jun 2025#54
c.inglethorpe, post #17: Adding a reference point for Clearance pathways. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted appropriately. Go to post

What I would tell a new member reading about Clearance pathways for the first time: the confident posts are not the reliable ones, and the reliable ones are longer.

27 likes in reply to #17 13mo
TF
taper_fileTL3Regular22 Jun 2025#59

A pharmacokinetic model fitted to trial data describes the population studied. Applying it to somebody outside the enrolled range is an extrapolation, and the model will not tell you it is.

I have left out the parts I could not verify.

26 likes 13mo
GD
glossary_deskTL3Regular27 Jun 2025#68

Coming back to post #66, because the follow-up matters more than the original answer.

Hepatic metabolism: the degree to which each compound is hepatically metabolised versus renally cleared is known but varies. Severe liver disease changes clearance.

33 likes 13mo

Read the full topic (70 posts)

Suggested topics

TopicParticipantsRepliesViewsActivity
Clearance pathways and what renal impairment changes
Clearance pathways and what renal impairment changes Writing it up because I had to work it out twice and would rather nobody else did. What changes if the standard account of clearance pathways is wrong? I…
BAWADAKLS+11 15 43k 2mo
Albumin binding and how it produces a long half-life
Albumin binding and how it produces a long half-life — setting out what I have, and where I think it stops being reliable. A narrow question about albumin binding, deliberately narrow, because the broad…
SDDMTBBTAM+38 44 6.6k 14mo
Follow-up: Subcutaneous absorption kinetics and site differences
Subcutaneous absorption kinetics and site differences — setting out what I have, and where I think it stops being reliable. A follow-up question about Subcutaneous absorption kinetics and site that I did not…
HCFPNVBICM 4 9.9k 10mo
Washout: how long is long enough, and for what purpose
Washout: how long is long enough, and for what purpose — setting out what I have, and where I think it stops being reliable. A narrow question about washout, deliberately narrow, because the broad version has…
BBNKPABRE+63 70 13k 10mo
Peak-to-trough ratio at steady state for a weekly agent
On the subject in the title: Peak-to-trough ratio at steady state for a weekly agent Working notes rather than a conclusion. Working through the kinetics rather than the pharmacology, because I think the…
SMVNICPAJH+58 64 9.7k 2mo

Related topics — sharing the tags missed dose, liraglutide, worked example

TopicParticipantsRepliesViewsActivity
Choosing a concentration on purpose rather than by accident
On the subject in the title: Choosing a concentration on purpose rather than by accident Working notes rather than a conclusion. Working notes on choosing a concentration rather than a conclusion. I would…
NLLWCD 2 719 1mo
A 10 mg vial reconstituted three different ways, compared — the long version
A 10 mg vial reconstituted three different ways, compared — the long version — setting out what I have, and where I think it stops being reliable. Asking about 10 mg vial reconstituted three directly, because…
JMBTEDAKSG+146 158 47k 9mo
Foaming during reconstitution and whether it matters — the long version
Foaming during reconstitution and whether it matters — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about Foaming during reconstitution,…
BFMDRMNGMM+100 117 6k 3mo
Drawing up with one needle and injecting with another
On the subject in the title: Drawing up with one needle and injecting with another Working notes rather than a conclusion. A question about technique rather than about dose. I have been doing the same thing…
KFIDFIOCH+1 5 6.9k 1d
Second pass at: Asking a follow-up: new topic or new reply?
The question in the title: Second pass at: Asking a follow-up: new topic or new reply? I will give what I have already checked below so nobody repeats it. Posting a small dataset on Asking a follow-up. It is…
JBTBTWEKSE 4 81 8mo